Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia

ClinicalTrials.gov ID: NCT00528905

Public ClinicalTrials.gov record NCT00528905. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 12, 2026, 7:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia

Study identification

NCT ID
NCT00528905
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AstraZeneca
Industry
Enrollment
400 participants

Conditions and interventions

Conditions

Interventions

  • AZD3480 Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2007
Primary completion
Sep 30, 2008
Completion
Oct 31, 2008
Last update posted
Nov 24, 2008

2007 – 2008

United States locations

U.S. sites
66
U.S. states
25
U.S. cities
66
Facility City State ZIP Site status
Research Site Little Rock Arkansas
Research Site Anaheim California
Research Site Cerritos California
Research Site Costa Mesa California
Research Site Escondido California
Research Site Garden Grove California
Research Site Long Beach California
Research Site Los Angeles California
Research Site Oceanside California
Research Site Pasadena California
Research Site Pico Rivera California
Research Site San Diego California
Research Site Santa Ana California
Research Site New Britain Connecticut
Research Site New Haven Connecticut
Research Site Washington D.C. District of Columbia
Research Site Boca Raton Florida
Research Site Coral Gables Florida
Research Site North Miami Florida
Research Site Orlando Florida
Research Site Tampa Florida
Research Site Atlanta Georgia
Research Site Augusta Georgia
Research Site Marietta Georgia
Research Site Chicago Illinois
Research Site Joliet Illinois
Research Site Schaumburg Illinois
Research Site Indianapolis Indiana
Research Site New Orleans Louisiana
Research Site Glen Burnie Maryland
Research Site Haverhill Massachusetts
Research Site Pittsfield Massachusetts
Research Site Minneapolis Minnesota
Research Site St Louis Missouri
Research Site Las Vegas Nevada
Research Site Nashua New Hampshire
Research Site Cherry Hill New Jersey
Research Site Clementon New Jersey
Research Site East Orange New Jersey
Research Site Newark New Jersey
Research Site Paramus New Jersey
Research Site Brooklyn New York
Research Site Cedarhurst New York
Research Site Elmsford New York
Research Site Glen Oaks New York
Research Site Jamaica New York
Research Site New York New York
Research Site Rochester New York
Research Site Staten Island New York
Research Site Cincinnati Ohio
Research Site Columbus Ohio
Research Site Kettering Ohio
Research Site Oklahoma City Oklahoma
Research Site Allentown Pennsylvania
Research Site DuBois Pennsylvania
Research Site Norristown Pennsylvania
Research Site Philadelphia Pennsylvania
Research Site Charleston South Carolina
Research Site Memphis Tennessee
Research Site Austin Texas
Research Site DeSoto Texas
Research Site Houston Texas
Research Site Irving Texas
Research Site San Antonio Texas
Research Site Richmond Virginia
Research Site Spokane Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00528905, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 24, 2008 · Synced May 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00528905 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →